The Top Line · Fierce Life Sciences

JPM26: Sunshine, AI and the deals that weren't

·17 min·1 clip
Why were the mega-deals missing at this year's J.P. Morgan Healthcare Conference despite perfect weather?
The episode analyzes the 2026 J.P. Morgan Healthcare Conference, highlighting the unusual lack of mega-deals, pervasive AI marketing, and quirky trends like Labubu dolls. Reporters discuss implications for biopharma M&A, AI's role in drug discovery, and China's rising influence as a competitive threat.

As heard by us

A muted JPM makes for a clear look at dealmaking, AI hype, and the mood underneath both.

The Top Line treats this year's J.P. Morgan Healthcare Conference as a market that showed up with less spectacle than usual. It works best when it leans into the missing megadeals, because that silence says more than the usual parade of announcements.

Read the full review in PlayNext →

Why you'd press play

You want the read on a quiet J.P.M., AI everywhere, and a Labubu cameo from Union Square.

Read the full recommendation in PlayNext →
Listen to the show on